Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Will depend on financials released after hours on the 14th
39.5% borrow rate yesterday for ACB
It will likely bleed until the Q on Thursday
39.5% loan rate today
Yep probably be a good week to do that
Aurora Cannabis Confirms Share Consolidation Effective Date
Source: PR Newswire (US)
NYSE | TSX: ACB
Common shares of the Company will begin trading on the New York Stock Exchange and the Toronto Stock Exchange on a post-consolidated basis at the opening of trading on May 11, 2020
EDMONTON, May 8, 2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, confirms today that it has received all necessary approvals for its previously announced consolidation of the common shares (the "Common Shares") of the Company on a 12 to 1 basis (the "Consolidation") and confirms that the Consolidation will be effective on May 11, 2020 (the "Effective Date").
not how they did it, they took the last ATM before the R/S there are no more ATM’s coming in the near future or hopefully ever. The PR they sent out a while back had the info in it.
This is the scenario every investor wanted from the start a crap load of cash, good revenues, low O/S and streamlined operations with low cost per gram.
109-135 mil O/S a 50 mil Q Operating cost with 70-75 mil per Q revenue and 250-300 mil cash on hand. Those are the numbers I am looking at post R/S
Like I said before it is a new company starting next week. We have not lost any business, the fat was cut way back and revenues should be ok.
The company generates revenue they just did not spend it wisely before. Those days are gone now and their goal is now profit over expansion. Booth is not at the ATM helm anymore so that shit stops after the R/S lol
GLTA
ATM’s are completed pre R/S resulting in more than 300 mil cash on hand and a final O/S in the 109-135 mil range.
Post R/S Q on the 14th
109-135 mil O/S
Quarterly Operating costs est. under 55 mil
Full production mode with 2.0 sales for the entire Q
Over 500 staff cut prior to current Covid events about 2 months should reflect in this Q
Germany issues resolved should reflect in this Q
Streamlined processes should drop production CPG to below .85
Stores were fully functional through this Q
All projects halted should reflect for 2 months in this Q resulting in major savings for the Q
This is how the company should have been operating for a long time when it was obvious the extra grow operations were not needed for many years to come.
With all the understandable negatives about the company I think it will change it’s ways and that will be evident in the coming Q. I am not saying all issues will be resolved, not by a long shot but this Q will be a determining factor on wether the company dies, survives or thrives.
Let’s face it if the company turns a profit anytime soon things will be much different after the R/S and a low O/S.
Here’s to hoping everyone can make a profit short or long.
GLTA
Long haul not day trading. Avg. is .21 for 105k shares I think at some point it will get back above that.
GLTA
Decided to start loading up will try and reach 100k shares before it hits .30
GLTA
Yea The Communist National Broadcast Center lol
Organigram Holdings Inc. Announces At-The-Market Equity Program
Source: Business Wire
Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX:OGI) (NASDAQ:OGI) announced today that it has established an at-the-market equity program (the “ATM Program”) that allows the Corporation to issue up to C$49,000,000 (or its U.S. dollar equivalent) of common shares (“Common Shares”) from treasury to the public from time to time, at the Corporation’s discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the NASDAQ Global Select Market (the “NASDAQ”) or any other marketplace on which the Common Shares are listed, quoted or otherwise traded, at the prevailing market price at the time of sale.
The volume and timing of distributions under the ATM Program, if any, will be determined in the Corporation’s sole discretion. The ATM Program will be effective until the earlier of December 25, 2021 and the issuance and sale of all of the Common Shares issuable pursuant to the ATM Program, unless terminated prior to such date by the Corporation or the agents referred to below. Organigram intends to use the net proceeds from the ATM Program, if any, to fund capital projects, for general corporate purposes and to repay indebtedness. As Common Shares distributed in the ATM Program will be issued and sold at the prevailing market price at the time of the sale, prices may vary among purchasers during the period of the distribution.
Distributions of the Common Shares through the ATM Program will be made pursuant to the terms of an equity distribution agreement dated April 22, 2020 among the Corporation, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent (collectively, the “agents”).
The offering under the ATM Program will be made pursuant to a prospectus supplement dated April 22, 2020 (the “Prospectus Supplement”) to the Corporation’s Canadian base shelf prospectus (the “Shelf Prospectus”) dated November 22, 2019, and pursuant to a prospectus supplement dated April 22, 2020 (the “U.S. Prospectus Supplement”) to the Corporation’s U.S. base prospectus (the “U.S. Base Prospectus”) dated November 22, 2019 and included in its registration statement on Form F-10, as amended (the “Registration Statement”) (File No. 333-234564). The Registration Statement was declared effective by the United States Securities and Exchange Commission (the “SEC”) on November 27, 2019. The Prospectus Supplement and the Shelf Prospectus are available on the SEDAR website maintained by the Canadian Securities Administrators at www.sedar.com, and the U.S. Prospectus Supplement, the U.S. Base Prospectus and the Registration Statement are available on EDGAR at the SEC’s website at www.sec.gov. Alternatively, the agents will send copies of the Prospectus Supplement and the Shelf Prospectus, or the U.S. Prospectus Supplement and the U.S. Base Prospectus, as applicable, upon request by contacting in Canada:
BMO Capital Markets, Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2, or by telephone at (905) 791-3151 Ext 4312, or by email at torbramwarehouse@datagroup.ca
or in the U.S.:
BMO Capital Markets Corp., Attention: Equity Syndicate Department, 3 Times Square, New York, NY 10036, or by telephone at (800) 414-3627, or by email at bmoprospectus@bmo.com
This news release does not constitute an offer to sell or the solicitation of an offer to buy the Common Shares, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Organigram Holdings Inc.:
Organigram Holdings Inc. is a NASDAQ and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.
Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Corporation 's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's primary facility is located in Moncton, New Brunswick and the Corporation is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
Forward-looking Information
This news release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation (collectively, “forward-looking information”). Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” and the negative of these terms, and other similar terminology or expressions have been used to identify the forward-looking information, which includes, without limitation, the aggregate value of Common Shares which may be issued pursuant to the ATM Program and the Corporation’s expected use of the net proceeds of the ATM Program, if any.
Forward-looking information involves known and unknown risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Although the Corporation believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur. For additional information with respect to certain of these assumptions, risks or factors, and risk factors relating to the Common Shares, reference should be made to the Corporation’s Prospectus Supplement and the Shelf Prospectus, or the U.S. Prospectus Supplement and the U.S. Base Prospectus, as applicable, the Corporation’s annual information form for the year ended August 31, 2019 and material change reports filed with the Canadian Securities Administrators available at www.sedar.com, or the Corporation’s annual report on Form 40-F and its reports on Form 6-K filed with the SEC and available at www.sec.gov, and such other continuous disclosure materials as may be filed from time to time by the Corporation with Canadian securities regulatory authorities and the SEC. The forward-looking information included in this news release is provided as of the date of this news release and the Corporation disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. We seek safe harbor.
For more information about Organigram please visit www.Organigram.ca.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200422005446/en/
Investor Relations Enquiries:
Amy Schwalm
Vice President, Investor Relations
(416) 704-9057
Amy.Schwalm@organigram.ca
Media Enquiries:
Ray Gracewood
Senior Vice President, Marketing and Communications
(506) 645-1653
ray.gracewood@organigram.ca
Yea I think that would do it.
Is Gates involved with this one?
I doubt they spend cash buying shares back after the R/S or before. That cash is slated for operating expenses only as all side projects other than research in the labs is pretty much halted. They need that cash to stay away from more dilution, if they buy back shares they will need to dilute more to raise more capital. With 109 or so mil O/S after the R/S, I think that is good so no need to do anything else with that, they stated their primary focus now is streamlining and profit over expansion.
If they have reduced operating costs down to 45-50 mil per Q and pull in over 75-80 mil per Q then that is a game changer and they are no longer running red in operations and that in turn equals profitability.
Like I said before a new company will emerge and with it a new CEO that is hell bent on making the company successful and profitable.
And the shorting begins!
Wow you decided to take that big of a hit you totally out?
I just bought in a small starter, hope they can execute.
GLTA
Well guess someone else shares some of my positive views on the R/S
https://us.yahoo.com/finance/news/aurora-cannabis-acb-not-reverse-125650343.html
Says prior to R/S in the prospectus
“The Company currently has 1,313,494,990 Common Shares outstanding and, assuming no additional Common Shares are issued prior to the Consolidation, the Consolidation will reduce the issued and outstanding Common Shares to approximately 109,457,915 Common Shares.”
The last ATM of 250 mil is done and the last several 100 mil days a few weeks ago were the ATM I think. and all this is done prior to R/S so if they issue more shares it will be prior to R/S
And yes technically you are correct, nowhere have I read that they will or will not issue more shares in the future so 50/50 chance but the ATM machine is done for a while if they are serious about staying listed imo
I saw nothing about post dilution of shares only pre. If you have different info please provide as I am going by what is in the prospectus just released, they upped the amount before R/S.
Those extra ATM shares are pre R/S from what I am reading so we should have a cash balance of close to 500 million on hand for the new company after the R/S with just over 100 million O/S and 60-90 mil Q’s.
I said new company because it will be focused on profit not expansion everything we need is already in place and fully operational.
I got into this company in 2016 @.34 and rode it to over $10 in 3 years had 100k shares at the start. I am sitting on 30k freebies which will be around 2500 post R/S. I had a 10 year plan and am sticking to it.
GLTA
No way I would eat 70k if I did not have too especially if there was not much left. I know everyone here will tell you to get out while you can but maybe I can cheer you up with an alternate scenario than the doom and gloom.
First the company has trimmed the fat, that is fact as they laid off more than 500 people and halted all non essential projects.
Second the company is still in full production and distribution mode even in the current environment. Our main grow op is so automated very few humans are needed.
Third is the 2.0 sales that started back in Dec. we should see a nice Q my guess is should be biggest Q yet.
Fourth is a new CEO after the R/S and Q are posted or around the same timeline give or take
The numbers I am looking at after R/S are what I think will propel the stock up.
The O/S will be just over 100 million
The production cost per gram should drop again, the write offs are done and the company is now streamlined for profit over expansion.
Think about a company with 100 mil O/S and 60-100 mil per Q
Food for thought instead of doom and gloom
GLTU in whatever you decide to do and it is only truly a loss when you sell, right now you are down but in 2 years you may be a millionaire no one knows for sure
Riding the storm out lol
For revenue you can look here
https://www.newcannabisventures.com/cannabis-company-revenue-ranking/
ACB has not officially delayed the Q3 release so best to just wait on them.
I am just wondering what it will look like with less than 200 mil O/S and a $100 mil Q
Q3 2020 comes out 5-12-2020
https://markets.businessinsider.com/stocks/acb/events
Actually the timing is going to coincide with the next Q. Right after the R/S they will post their biggest Q yet so there may be an upside if they post well over 100mil in May, if not then it is down down down until they hit $150 mil Q to bring PPS back up imo
GLTA in these crazy azz times
I would say the current situation around the globe will put a huge damper on the illicit drug trade. My guess is after a few months of no sales the black markets will start drying up. I guess this is one way to help curb the illicit black markets and instill legitimate businesses as the norm for Cannabis instead of your drug dealing buddy lol
GLTA
Looks like Canadian Cannabis and Alcohol businesses will get some help from Canadian Uncle Sam ehhhhh!
https://www.theglobeandmail.com/canada/article-bars-cannabis-sector-eligible-for-40-billion-credit-program-from/
PPS range for that GAP fill?
Are online sales opened up throughout Canada or just specific provinces?
I am in also
What made you decide to look at Radient was it something in the chart?
10.5 mil volume in 15 minutes looks like another 100+ mil day in the works
Oh damn I just read this and it looks very promising, think I will grab another chunk this week.
Thanks for the DD
More risk. I already have ACB, RTI, OGI, Khiron, and Choom I am loaded pretty well on all of them now. I am mainly just interested in Khiron right now. I have allocated some funds to add more Khiron if I deem it a good opportunity for quick gains.
I am not a chartist so I don’t really follow those trends, I am more of an investor. I am trying to pick a few companies that will give me a good return in a year or so.